ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

CDC Awaits Results Of Viral Cultures Of Bahama’s Serum For AIDs Contamination Before Taking Action

July 19, 1985

Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy

October 27, 1978

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992